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Background: The Northern part of Senegal is characterized by a low and seasonal transmission of malaria.
However, some Plasmodium falciparum infections and malaria clinical cases are reported during the dry season. This
study aims to assess the relationship between IgG antibody (Ab) responses to gSG6-P1 mosquito salivary peptide
and the prevalence of P. falciparum infection in children during the dry season in the Senegal River Valley. The
positive association of the Ab response to gSG6-P1, as biomarker of human exposure to Anopheles vector bite, and
P. falciparum infectious status (uninfected, infected-asymptomatic or infected-symptomatic) will allow considering
this biomarker as a potential indicator of P. falciparum infection risk during the dry season.
Methods: Microscopic examination of thick blood smears was performed in 371 and 310 children at the start
(January) and at the end (June) of the dry season, respectively, in order to assess the prevalence of P. falciparum
infection. Collected sera were used to evaluate IgG response to gSG6-P1 by ELISA. Association between
parasitological and clinical data (infected-asymptomatic or infected-symptomatic) and the anti-gSG6-P1 IgG levels
were evaluated during this period.
Results: The prevalence of P. falciparum infection was very low to moderate according to the studied period and
was higher in January (23.5%) compared to June (3.5%). Specific IgG response was also different between
uninfected children and asymptomatic carriers of the parasite. Children with P. falciparum infection in the dry
season showed higher IgG Ab levels to gSG6-P1 than uninfected children.
Conclusions: The results strengthen the hypothesis that malaria transmission is maintained during the dry season
in an area of low and seasonal transmission. The measurement of IgG responses to gSG6-P1 salivary peptide could
be a pertinent indicator of human malaria reservoir or infection risk in this particular epidemiological context. This
promising immunological marker could be useful for the evaluation of the risk of P. falciparum exposure observed
during dry season and, by consequences, could be used for the survey of potential pre-elimination situation.
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Malaria transmission in the Northern part of Senegal
is low and occurs mainly between August and October
due to a single rainy season from July to October [1].
This situation creates breeding sites for two members of
the Anopheles gambiae complex (An. gambiae s.s. and
Anopheles arabiensis) and for Anopheles funestus, which
breed in fresh water and in swampy habitats with much
vegetation, respectively. In this area, Plasmodium falciparum
is virtually the only species of Plasmodium. The incidence of
clinical cases and mortality peaks between September and
November, and then rapidly declines. According to statis-
tical data of the National Malaria Control Programme
(NMCP), this region of Senegal presents the lowest na-
tional malaria attack rates, with less than five malaria de-
clared cases per 1,000 inhabitants in 2009 [2], and could,
therefore, be an interesting area of study in the scope of
local malaria pre-elimination.
In several epidemiologic studies, a proportion of P.
falciparum human carriers were found during the dry
season, despite a very low level of parasite transmission
[3-5]. The small numbers of clinical cases of malaria ob-
served during the middle and at the end of the dry season
are considered to be mostly due to parasitological yearly
recrudescence. Some infected individuals carry gameto-
cytes throughout the dry season, potentially inducing mal-
aria transmission if vectors are present during this period
[6]. In Northern Senegal, the construction of two dams on
the Senegal River has enabled the enlargement of irrigated
areas and the expansion of rice growing, providing bree-
ding sites for mosquitoes. This situation could contribute
to the maintenance of malaria transmission during the dry
season [7]. The identification of P. falciparum carriers in
human populations and the evaluation of their risks of ex-
posure to malaria vectors are needed to carry out an ef-
fective malaria control in this particular area, considered
suitable for malaria pre-elimination by the NMCP.
During its blood meal, the Anopheles mosquito injects
saliva into the vertebrate host. The study of salivary pro-
teins and their effects on the immune response of verte-
brate host represents an innovative research tool to
characterize the mechanisms of pathogens’ transmis-
sion. Therefore, the study of human-vector relationship
appeared promising in the perspective of an effective
control of vector-borne diseases. Numerous studies
have shown that Anopheles salivary proteins are anti-
genic. In particular, it has been shown that children li-
ving in malaria-endemic areas developed IgG response
to whole saliva of An. gambiae which was associated
with the intensity of human exposure to vector bites [8].
Moreover, this specific antibody (Ab) response was pre-
dictive of malaria morbidity [8]. It was also observed that
individuals with P. falciparum or Plasmodium vivax infec-
tion showed higher IgG response to Anopheles dirus [9]and Anopheles darlingi saliva [10], than uninfected indi-
viduals. In addition, one study showed that specific IgG
Ab response to An. gambiae saliva may also be useful for
assessing exposure in travellers, and thus could be a bio-
marker of vector exposure in individuals weakly and tran-
siently exposed to Anopheles bites [11]. Altogether, the
specific IgG Ab response to Anopheles salivary proteins
represents an immunological marker of human exposure
to vector bites and thus a potential indicator of the risks
of Plasmodium transmission, as observed for various
vector-borne diseases [12,13]. With the aim to develop a
specific, simple and reproducible biomarker, one synthetic
peptide (gSG6-P1) of the An. gambiae (gSG6) protein has
been identified and validated as a biomarker candidate of
exposure to Afro-tropical malaria vectors [14,15]. Indeed,
gSG6-P1 is antigenic, highly specific to Anopheles and it
was demonstrated that specific IgG response was espe-
cially a relevant biomarker in a context of low and sea-
sonal exposure to malaria vectors [16-18].
This present study aimed i) to appraise the prevalence
of P. falciparum infection during the dry season in the
Senegal River valley and ii) to evaluate the association
between IgG responses to gSG6-P1 salivary peptide and
different clinical statuses (uninfected, asymptomatic,
symptomatic) of P. falciparum infection in children. The
final objective was to assess the potential use of the
gSG6-P1 as a biomarker of P. falciparum infection risk
during dry season.
Methods
Study site and population
The study was conducted in Northern Senegal, in the
Senegal River Valley. This site is a typical sahelian area
with less than 400 mm of rainfall per year. Malaria trans-
mission is described as low, seasonal and occurs mainly
during the rainy season between August and October with
a rate of infective bites/person/night <1 [19].
A longitudinal follow-up was performed from October
2008 to January 2010 in children between one and nine
years of age, in Agniam, Niandane, Pendao, Guede and
Fanaye, as previously described [18,20]. In the present
study, only children present at both the beginning and
the end of the dry season of 2009 (January and June)
were included in parasitological and immunological ana-
lyses. The characteristics of the studied population
(number of children, age, and gender) are described in
Table 1. Most of the study population belonged to the
Fulani ethnic group.
Ethics statement
The present study was approved by the National Ethics
Committee of the Ministry of Health of Senegal (October
2008; 0084/MSP/DS/CNRS, clinicaltrials.gov/ct2/show/
NCT01545115). Oral and written informed consents
Table 1 Characteristics of the studied population in the dry season, parasitological and immunological data
Dry seasona January 2009 June 2009
Nb of children 681 371 310
Age, mean ± SD (years) 5.52 ± 2.5 5.27 ± 2.6 5.77 ± 2.4
Sex ratio (male/female)(%) 341/681 (50%) 188/183 (50.6%) 153/157 (49.4%)
Prevalence of P. falciparum infection (%)b 98/681 (14.4%) 87/371 (23.5%) 11/310 (3.5%)
Gametocyte carriage (%) 7/681 (1.0%) 3/371 (1.0%) 3/310 (1.0%)
% responders IgG anti-gSG6-P1c 102/681 (14.9%) 59/371 (15.9%) 43/310 (13.9%)
aCumulative data for January and June 2009.
bAll P. falciparum infection (malaria positive blood smear) with and without symptoms.
cNumber and percentage (%) of immune responders of IgG Ab to An. gambiae gSG6-P1 peptide.
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Study design
The design of the entomological, parasitological and im-
munological monitoring (from October 2008 to January
2010, including wet and dry seasons) of each village
(Agniam, Niandane, Pendao, Guede and Fanaye) have
been previously reported [18]. This present study fo-
cused on visits conducted during the dry season (January
and June 2009). Exposure to Anopheles bites was ex-
tremely low in this area during the dry season and
remained similar between villages [18]. Therefore, ento-
mological (Human Biting Rate, HBR), immunological
(percentage of IgG responders to gSG6-P1) and parasito-
logical data (parasite prevalence and gametocyte car-
riage) in the present study represented the mean values
of these five villages during the dry season.
Parasitological, immunological and clinical survey
681 thick blood smears were collected during the two
mentioned visits (January and June 2009) to estimate P.
falciparum prevalence and gametocyte carriage. The
slides were transferred to a nearby laboratory, stained
with Giemsa and analysed under a microscope by expe-
rienced technicians. In parallel, sera collected by finger
prick into BD microtainer® tubes (Franklin Lakes, New
Jersey, USA) were centrifuged and 300 μL of serum was
collected and stored at −20°C until use for immuno-
logical tests by ELISA. Axillary temperature of each par-
ticipant was also measured.
Study definitions
According to the P. falciparum malaria diagnosis and the
clinical status of the disease, children were stratified in
three different groups: uninfected (negative malaria blood
smear), infected-asymptomatic and infected-symptomatic
(positive malaria blood smear, PMBS). Children presenting
a PMBS (P. falciparum infection) without any clinical sign,
fever (axillary temperature ≥37.5°C) and/or a history of
fever reported during the corresponding month, wereconsidered infected-asymptomatic; while in the presence
of fever and/or history of fever, they were classified as
infected-symptomatic.
Entomological data
Entomological data collected by human landing catches
and Pyrethrum spray catches during the follow-up were
previously reported and An. gambiae s.l. (An. arabiensis,
An. gambiae S and An. gambiae M) have been described as
the predominant species and the only vectors of P. falcip-
arum [19]. Other species such as An. funestus, Anopheles
wellcomei, Anopheles pharoensis and Anopheles ziemanni
were also collected in low densities. At each visit, ento-
mological sampling was performed using four adult vol-
unteers per village (two indoors and two outdoors).
Human Biting Rate (HBR) was estimated by the number
of bites per person per night (BHN). It was calculated
by dividing the number of An. gambiae caught by the
total person-night for the period [19].
Salivary peptide gSG6-P1
The gSG6-P1 peptide was designed using bioinformatics
to maximize its Anopheles specificity and its immuno-
genicity, as previously described [14,15]. It was synthe-
sized and purified (>95%) by Genepep SA (Saint Jean de
Védas, France). Peptide was shipped in lyophilized form
and then suspended in 0.22 μm ultra-filtered water and
frozen at −20°C until use.
Evaluation of anti-human IgG level to gSG6-P1 antigen
by ELISA
ELISAs were carried out on sera to quantify IgG response
to the gSG6-P1 peptide as previously described [18].
Briefly, Maxisorp plates (Nunc, Roskilde, Danemark) were
coated with gSG6-P1 (20 μg/ml) in PBS (Phosphate Buf-
fered Saline). After washing (distilled water + Tween
0.1%), each serum were incubated in duplicate at 4°C
overnight at a 1/20 dilution (in PBS with 1% Tween).
Mouse biotinylated Ab to human IgG (BD Pharmingen,
San Diego CA, USA) was incubated at a 1/2000 dilution
in PBS with 1% Tween (1 h30 at 37°C) and peroxidase-
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then added (1/2,000; 1 h at 37°C). Colorimetric deve-
lopment was carried out using ABTS (2.2′-azino-bis
(3 ethylbenzthiazoline 6-sulfonic acid) diammonium;
Sigma, St Louis, MO, USA) in 50 mM citrate buffer
(Sigma, pH = 4, containing 0.003% H2O2) and absorb-
ance (OD) was measured at 405 nm.
Individual results were expressed as the ΔOD value:
ΔOD =ODxODn, where ODx represents the mean of
individual optical density (OD) value in both wells with
gSG6-P1 antigen and ODn the individual OD value for
each serum without gSG6-P1 antigen. Specific anti-
gSG6-P1 IgG response were also assayed in non-Anopheles
exposed individuals (n = 12 – neg; North of France) in
order to quantify the non-specific background Ab level
and to calculate the specific immune response threshold:
TR =mean (ΔODneg) + 3SD = 0.180. An exposed indi-
vidual was then classified as an immune responder (IR)
if its ΔOD> 0.180.
Statistical analysis
Data were analysed with Graph Pad Prism® (Graph Pad
Software, San Diego, USA). Chi2 test was used to com-
pare P. falciparum prevalence between January and June,
and also between IgG immune responders to gSG6-P1
and non-responders. Mann–Whitney U test was used
for the comparison of IgG levels between uninfected and
infected-asymptomatic or infected-symptomatic children.
The same test was used to compare differences between
uninfected and infected children. Differences of IgG re-
sponse levels between more than three groups were calcu-
lated using the non parametric Kruskal-Wallis test. The
association between P. falciparum infection and immune
responders to gSG6-P1 peptide was calculated using the
relative risk (RR), and 95% confidence intervals (CI) were
calculated by the Miettinen method. All differences were
considered significant at p < 0.05.
Results
Malaria infection during the dry season
As indicated in Table 1, 681 children have been included
during the dry season (371 in January 2009 and 310 in
June 2009) among them 304 were present at both visits.
Mean age and sex ratio were similar at both visits.
Microscopic examination of thick blood smears revealed
some P. falciparum infection in children during dry sea-
son. The prevalence of P. falciparum infection was
higher in January 2009 (23.5%) than in June 2009 (3.5%)
(p < 0.001, Chi2 Test). No difference in P. falciparum in-
fection was observed between children under 5 years of
age and the older ones (Additional file 1). Only nine
clinical cases of malaria were recorded during both
visits, six in January 2009 (1.6%) and three in June 2009
(1%). Gametocyte carriage during this period remainedvery low (1%). HBR was also very low and was estimated
at 0.3 during the cold dry season (January 2009) and
1.52 during the hot dry season (June 2009) [18]. This
low exposure to Anopheles bites was confirmed by im-
munological data that showed 14.9% of IgG responders
to gSG6-P1 (Table 1). In addition, no infected Anopheles
were collected during this dry season in the area (Ento-
mological Inoculation Rate, EIR = 0) [19].
IgG response levels to gSG6-P1 according to
malaria infection
First, differences of specific IgG response levels to gSG6-P1
salivary peptide were compared between individuals with P.
falciparum infection (children who presented a PMBS,
infected-symptomatic or infected-asymptomatic) and unin-
fected. Comparison showed that the median of specific IgG
Ab level was significantly higher in P. falciparum-infected
children compared to uninfected ones during the dry sea-
son (p < 0.01, Figure 1A, Mann–Whitney U Test). A si-
milar pattern of specific IgG level according to malaria
infection was observed in January (p = 0.02, Figure 1B)
and in June (p < 0.01, Figure 1C).
IgG response levels to gSG6-P1 according to
malaria status
The specific IgG Ab response to gSG6-P1 was then
analysed according to the three different statuses of P. fal-
ciparum infection (uninfected, infected-asymptomatic and
infected-symptomatic) during the dry season (Figure 2;
cumulative data for January and June 2009). The anti-
gSG6-P1 IgG levels were significantly different accor-
ding to the status of P. falciparum infection (p = 0.003,
Kruskal-Wallis Test). Indeed, specific IgG responses were
significantly higher in both infected-asymptomatic and
infected-symptomatic children compared to uninfected
ones (p < 0.01 and p = 0.04, Mann–Whitney U test, res-
pectively). But, no statistical difference was observed
in IgG Ab responses between infected-asymptomatic
and infected-symptomatic children, (p = 0.43, Mann–
Whitney U test). Similar results were obtained when
data were analysed separately in January and in June
2009 (Additional file 2). IgG response levels remained
higher in infected-asymptomatic children compared to
uninfected ones (p < 0.05). Nevertheless, there was no
difference either between uninfected and infected-
symptomatic or between infected-asymptomatic and
infected-symptomatic.
IgG response levels to gSG6-P1 and P. falciparum
infection risk
To examine if the evaluation of specific IgG Ab levels to
gSG6-P1 could be a suitable method to estimate the pro-
bability of P. falciparum infection during the dry season,
i.e. under conditions of low transmission, prevalence of
Figure 1 IgG response levels to gSG6-P1 peptide from
non-infected and infected children. Box plots indicate IgG
response (ΔOD) values to gSG6-P1 peptide from uninfected
individuals and children with P. falciparum infection during the
whole dry season (cumulative data) (A), in January 09 (B) and in
June 09 (C). Boxes display the median ΔOD value, 25th and 75th
percentiles. The whiskers show the 5th/95th percentiles and the dots
indicate the outliers. The P value was determined according to the
Mann–Whitney U test.
Figure 2 IgG response levels to gSG6-P1 peptide according to
malaria status. Box plots show anti-gSG6-P1 IgG level (ΔOD)
between uninfected, infected-asymptomatic and infected-
symptomatic individuals (cumulative data from January and June
2009). Boxes display the median ΔOD value, 25th and 75th percentiles.
The whiskers show the 5th/95th percentiles and the dots indicate the
outliers. Differences between two or three groups were tested using
Mann Whitney test and Kruskal Wallis test, respectively.
Sagna et al. Malaria Journal 2013, 12:301 Page 5 of 9
http://www.malariajournal.com/content/12/1/301P. falciparum infection was compared between immune
IgG responders to gSG6-P1 (ΔOD> 0.180) and non-im-
mune responders (ΔOD ≤ 0.180) (Figure 3). Positive and
significant association between malaria infection preva-
lence and immune responder to gSG6-P1 was observed.
Indeed, the risk of P. falciparum infection was 2–7 times
higher in immune responders than in non-responders dur-
ing the dry season (Figure 3A; relative risk [RR] = 2.504,
95% CI: 1.70-3.67, p < 0.001, Chi2 test), in January
(Figure 3B; RR = 2.014, 95% CI: 1.34-3.00, p < 0.001)
and in June (Figure 3C; RR = 7.451, 95% CI: 3.08-17.97,
p < 0.0001). Taken together, these data suggest that posi-
tive IgG response to gSG6-P1 could be a pertinent and re-
liable indicator for suspected P. falciparum infection in
individuals living in a low transmission context.
Discussion
In the first part of the study, P. falciparum infection in
the human population during the dry season was investi-
gated in the Senegal River Valley reported as a low ma-
laria transmission setting [19]. P. falciparum infection
was observed during the dry season and was higher in
January (23.5%) than in June (3.5%). This finding con-
firmed previous studies in a neighbouring area [21,22] in
which a moderate P. falciparum infection rate decreases
throughout the dry season (December to June) [18].
The paradox observed in this area, between low or no
transmission (EIR = 0) and high or moderate malaria
parasite prevalence, has previously been described in a
neighbouring area [21] and elsewhere in Africa [23-25].
Figure 3 Plasmodium falciparum prevalence between IgG
responders and non-responders to gSG6-P1 peptide. Data
present the rate of P. falciparum infection according to the two
defined immune responder groups: non-responders to gSG6-P1
(ΔOD ≤ 0.180) and responders to gSG6-P1 (ΔOD > 0.180) during the
whole dry season (cumulative data) (A), in January 09 (B) and in
June 09 (C). Statistical significant difference between these two
groups is indicated using a Chi2 test.
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relationships between the EIR indicator and its perti-
nence, and the prevalence of malaria infection. The ab-
sence of infection in Anopheles could be explained by a
lack of sensitivity of entomological sampling methods
used, in a special context where a very small number
of An. gambiae s.l. is collected. Indeed, An. gambiae s.s
and An. arabiensis were already proven to be highly
anthropophilic and predominant malaria vectors in the
Senegal River Valley [19]. Anopheles infection rate of
1.37% was observed one year later during the dry season
[19]. This suggests that malaria transmission could occur
during the dry season between November and June cor-
responding to off-season agriculture. However, its inten-
sity could differ from one year to another [1]. Thus,
irrigated fields’ crops, annual flood of the river, tempor-
ary ponds or ditches could provide breeding sites for
remaining Anopheles [19,26,27], and thereby contribute
to malaria transmission during the dry season. However,
it should be noticed that very few clinical cases of mal-
aria were recorded in this area during the dry season.
Indeed, the Senegalese NMCP reported in 2009 less than
five malaria cases per 1,000 inhabitants of the River
Valley [2]. In our study, most of infected children were
asymptomatic carriers of the parasite and the identifica-
tion of such individuals could be very relevant for a bet-
ter malaria control, especially during the dry season and
in areas of malaria pre-elimination.
In this regard, the present study shows that IgG re-
sponse to gSG6-P1 was higher in infected-asymptomatic
children than in uninfected ones. Statistical significance
between infected-asymptomatic and uninfected children
was stronger (p < 0.01) when data were cumulated (January
and June 2009); probably due to the huge amount of over-
lap between groups during these two visits. However,
IgG response to gSG6-P1 peptide remained significantly
higher in infected-asymptomatic children than in un-
infected ones when data were analysed separately in
January (p = 0.04) and in June (p = 0.02). So, IgG re-
sponse to An. gambiae gSG6-P1 salivary peptide could
be a pertinent biomarker of P. falciparum asymptomatic in-
fection. Such a distinction of asymptomatic P. falciparum
infected individuals compared to uninfected children ap-
pears considerable for malaria control in low endemicity
areas, and especially during the dry season. Indeed, most of
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and long-term asymptomatic carriage of P. falciparum
throughout the dry season is commonly observed [3,4,28].
Infected-asymptomatic individuals could serve as a crucial
reservoir for the parasite and could transmit P. falciparum
to uninfected Anopheles vectors which remain after the
rainy season, contributing to the maintenance of malaria
transmission in the dry season and its re-starting after the
first rains [5,29]. Therefore, monitoring the IgG response to
gSG6-P1 salivary peptide as a biomarker of P. falciparum
asymptomatic infection could be used as a valuable tool in
a malaria pre-elimination context.
In addition, the present study showed that high IgG
levels to gSG6-P1 could be predictive indicators of P.
falciparum infection. This result is in accordance with
previous results in Senegal showing that children with
subsequently clinical P. falciparum malaria presented
higher anti-saliva IgG response than did non-infected
children [8]. In addition, Andrade et al. [10] have
showed that higher anti-An. darlingi saliva Ab response
could indicate human exposure to P. vivax and bio-
marker of P. vivax in Brazil. Recently, a study in
Burkina-Faso showed a positive correlation between
malaria incidence and IgG response against the recom-
binant protein of An. gambiae (gSG6) [30]. In Kenya, it
has also been indicated that parasite prevalence was
associated with the increase of anti-gSG6-P1 IgG preva-
lence [31]. Altogether, these results suggest that anti-
saliva (or protein/peptide) Ab response, previously
demonstrated to be biomarker of exposure to Anopheles
bites in numerous contexts, could also be a useful indi-
cator of malaria infection and/or morbidity risks in this
particular context. It is quite conceivable that salivary
peptides could complete in the near future, routine
thick blood smears performed in the framework of ac-
tive case detection of malaria infection or in the evalu-
ation of vector control strategies. Indeed, it was shown
that it was possible to assess by ELISA, IgG response to
gSG6-P1 on eluates of blood drops collected on blotting
paper [16,32,33]. This sampling technique could be
performed concomitantly to thick blood smears and
would allow making several molecular analyses (DNA
sequencing of organisms, modern diagnostic techniques
based on biomarkers detection.) on the same sample.
This method is therefore suitable for multidisciplinary
large-scale studies [34]. Furthermore, it is also conceiv-
able to develop such immunological biomarker by the
use of a simple self-test strip, like rapid diagnostic test
(RDT). This would rapidly identify people at risk or
even asymptomatic malaria infected individuals and
begin early treatment. Nevertheless, the use of biomarkers
of human exposure to Anopheles bites as an immu-
nological indicator of disease risk remains to be largely
studied. For example, there is a lack of a conventionalthreshold of immune response to salivary proteins/peptide
at which an individual is at risk of malaria infection. The
intensity of exposure or transmission varies according to
the area and season. Despite these limitations, data of the
current study indicate the potentiality to use biomar-
kers of human exposure to vectors as a reliable and
useful tool to detect malaria human reservoirs and
help predicting malaria risk, and this in a context of
very low exposure to vectors, such as malaria pre-
elimination settings. This point appeared to be clearly
relevant in regard to the observed results in June
(end of dry season with very low exposure to Ano-
pheles bites) where the risk of P. falciparum infection
was seven times higher in immune responders than
in non-responders.
A limitation of this study could be linked to an under-
evaluation of P. falciparum infection prevalence during
the dry season, since it was only determined by micros-
copy examination. However, this gold standard technique
for malaria screening has limited sensitivity for detection
of very low parasite densities. Indeed, it has been shown
that, in areas with low or very low intensity of malaria
transmission, sub-microscopic infections were commonly
seen [35,36]. It would be important to improve this
detection using more sensitive methods such as gene
amplification by Polymerase Chain Reaction (PCR)
[37-39]. Nevertheless, the presence of P. falciparum in-
fection has been revealed with microscopic detection,
suggesting that malaria transmission occurs during the
dry season in this area.
Conclusions
During the low-transmission season (dry season), P.
falciparum infections were observed in the Northern
Senegal River Valley. Parasitological data have been corre-
lated with anti-gSG6-P1 IgG responses, indicating that this
Anopheles salivary-antigen specific response could be a per-
tinent epidemiological biomarker of P. falciparum exposure
during the dry season. Furthermore, the analysis revealed
that high levels of gSG6-P1 specific IgG response could be
used as an indicator of infection risk and even to discrimin-
ate uninfected and infected-asymptomatic carriers of the
parasite during the dry season. This biomarker could be
very useful for national malaria control programs to identify
asymptomatic carriers of P. falciparum in low and seasonal
transmission areas and, by consequences, in a context of
malaria pre-elimination.
Additional files
Additional file 1: Prevalence of P. falciparum infection during the
dry season, stratified by age group. The table summarizes P.
falciparum infection between children under 5 years of age and the older
ones during the dry season.
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to malaria status. Box plots show gSG6-P1 specific IgG response levels
(ΔOD) according to three P. falciparum infection statuses. Boxes display
the median ΔOD value, 25th and 75th percentiles. The whiskers show the
5th/95th percentiles and the dots indicate the outliers. Differences
between two or three groups were tested using Mann Whitney test and
Kruskal Wallis test, respectively.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ABS participated in field surveys, carried out the immunological assessments,
analysed data and drafted the manuscript. JBS, LG, SS, MP, AMS, EH, NF
participated in study coordination, field surveys, data collection and
microscopic examination. SBC participated to data analysis. GR and FR
participated in study design, preparation and writing of the manuscript.
All authors contribute to revision the manuscript and read and approved the
final version.
Acknowledgements
We gratefully acknowledge the populations of Agniam, Niandane, Guede,
Ndiayene Pendao and Fanaye, and all the health care agents of the district
of Podor, for their participation in the study. We also thank Soihibou Guindo
(CRB-EPLS) for his technical and useful assistance in the field. ABS was
supported by a fellowships provided by CRB-EPLS. This research was
supported by the Biomedical Research Center Espoir Pour La Santé (EPLS)
and the Research Institute for Development (IRD-Direction de la Valorisation
au Sud) with a financial participation of the FSD “Fond Social de
Développement”, (BIOMARQPAL ref 2008–5901) Embassy of France in
Senegal.
Author details
1Centre de Recherche Biomédicale Espoir Pour La Santé, 269 Route de la
corniche, Sor, BP: 226, Saint-Louis, Sénégal. 2Département de Biologie
Animale, Laboratoire de parasitologie générale, Université Cheikh Anta Diop,
Dakar, Sénégal. 3CIIL, Inserm U1019, CNRS UMR 8204, Université Lille Nord de
France, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019 Lille cedex,
France. 4Institut de Recherche pour le Développement, UMR 224 MIVEGEC,
911 avenue Agropolis, BP: 64501F-34394 Montpellier, France. 5Centre de
Recherche Entomologique de Cotonou, BP: 4414, Cotonou RP 01, Bénin.
Received: 26 June 2013 Accepted: 27 August 2013
Published: 30 August 2013
References
1. Ministry of Health and Prevention of Senegal: National Strategic Plan
2011–2015. Dakar: National Malaria Control Programme; 2010.
2. Ministry of Health and Prevention of Senegal: Statistical report 2009. Dakar:
National Malaria Control Programme; 2010.
3. Babiker HA, Abdel-Muhsin AM, Ranford-Cartwright LC, Satti G, Walliker D:
Characteristics of Plasmodium falciparum parasites that survive the
lengthy dry season in eastern Sudan where malaria transmission is
markedly seasonal. Am J Trop Med Hyg 1998, 59:582–590.
4. Hamad AA, Nugud Ael H, Arnot DE, Giha HA, Abdel-Muhsin AM, Satti GM,
Theander TG, Creasey AM, Babiker HA, Elnaiem DE: A marked seasonality
of malaria transmission in two rural sites in eastern Sudan. Acta Trop
2002, 83:71–82.
5. Zwetyenga J, Rogier C, Spiegel A, Fontenille D, Trape JF, Mercereau-Puijalon
O: A cohort study of Plasmodium falciparum diversity during the dry
season in Ndiop, a Senegalese village with seasonal, mesoendemic
malaria. Trans R Soc Trop Med Hyg 1999, 93:375–380.
6. Paul RE, Diallo M, Brey PT: Mosquitoes and transmission of malaria
parasites - not just vectors. Malar J 2004, 3:39.
7. Richel R, Sondaz D, Philip J, Calvet F, Daoud W: Le bassin versant du fleuve
Sénégal, situation sanitaire en 2010. Med Trop 2010, 71:223–228.
8. Remoue F, Cisse B, Ba F, Sokhna C, Herve JP, Boulanger D, Simondon F:
Evaluation of the antibody response to Anopheles salivary antigens as a
potential marker of risk of malaria. Trans R Soc Trop Med Hyg 2006,
100:363–370.9. Waitayakul A, Somsri S, Sattabongkot J, Looareesuwan S, Cui L,
Udomsangpetch R: Natural human humoral response to salivary gland
proteins of Anopheles mosquitoes in Thailand. Acta Trop 2006, 98:66–73.
10. Andrade BB, Rocha BC, Reis-Filho A, Camargo LM, Tadei WP, Moreira LA,
Barral A, Barral-Netto M: Anti-Anopheles darlingi saliva antibodies as
marker of Plasmodium vivax infection and clinical immunity in the
Brazilian Amazon. Malar J 2009, 8:121.
11. Orlandi-Pradines E, Almeras L, de Denis Senneville L, Barbe S, Remoue F,
Villard C, Cornelie S, Penhoat K, Pascual A, Bourgouin C, Fontenille D,
Bonnet J, Corre-Catelin N, Reiter P, Pages F, Laffite D, Boulanger D,
Simondon F, Pradines B, Fusai T, Rogier C: Antibody response against
saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in
tropical Africa. Microbes Infect 2007, 9:1454–1462.
12. Billingsley PF, Baird J, Mitchell JA, Drakeley C: Immune interactions
between mosquitoes and their hosts. Parasite Immunol 2006, 28:143–153.
13. Remoue F, Cornelie S, Ngom A, Boulanger D, Simondon F: Immune
responses to arthropod bites during vector-borne diseases, Update in tropical
immunology. Herala, India: Fort P.O. Trivandrum; 2005:377–400.
14. Poinsignon A, Cornelie S, Mestres-Simon M, Lanfrancotti A, Rossignol M,
Boulanger D, Cisse B, Sokhna C, Arca B, Simondon F, Remoue F: Novel
peptide marker corresponding to salivary protein gSG6 potentially
identifies exposure to Anopheles bites. PLoS One 2008, 3:e2472.
15. Poinsignon A, Samb B, Doucoure S, Drame PM, Sarr JB, Sow C, Cornelie S,
Maiga S, Thiam C, Rogerie F, Guindo S, Hermann E, Simondon F, Dia I, Riveau G,
Konate L, Remoue F: First attempt to validate the gSG6-P1 salivary peptide as
an immuno-epidemiological tool for evaluating human exposure to
Anopheles funestus bites. Trop Med Int Health 2010, 15:1198–1203.
16. Drame PM, Machault V, Diallo A, Cornelie S, Poinsignon A, Lalou R,
Sembene M, Dos Santos S, Rogier C, Pages F, Le Hesran JY, Remoue F:
IgG responses to the gSG6-P1 salivary peptide for evaluating human
exposure to Anopheles bites in urban areas of Dakar region. Senegal.
Malar J 2012, 11:72.
17. Poinsignon A, Cornelie S, Ba F, Boulanger D, Sow C, Rossignol M, Sokhna C,
Cisse B, Simondon F, Remoue F: Human IgG response to a salivary
peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating
low-level exposure to Anopheles bites. Malar J 2009, 8:198.
18. Sagna AB, Sarr JB, Gaayeb L, Drame PM, Ndiath MO, Senghor S, Sow CS,
Poinsignon A, Seck M, Hermann E, Schacht AM, Faye N, Sokhna C, Remoue
F, Riveau G: gSG6-P1 salivary biomarker discriminates micro-geographical
heterogeneity of human exposure to Anopheles bites in low and
seasonal malaria areas. Parasit Vectors 2013, 6:68.
19. Ndiath MO, Sarr JB, Gaayeb L, Mazenot C, Sougoufara S, Konate L, Remoue
F, Hermann E, Trape JF, Riveau G, Sokhna C: Low and seasonal malaria
transmission in the middle Senegal River basin: identification and
characteristics of Anopheles vectors. Parasit Vectors 2012, 5:21.
20. Gaayeb L, Sarr JB, Ndiath MO, Hanon JB, Debrie AS, Seck M, Schacht AM,
Remoue F, Hermann E, Riveau G: Seroprevalence of pertussis in Senegal: a
prospective study. PLoS One 2012, 7:e48684.
21. Dia I, Konate L, Samb B, Sarr JB, Diop A, Rogerie F, Faye M, Riveau G, Remoue F,
Diallo M, Fontenille D: Bionomics of malaria vectors and relationship with
malaria transmission and epidemiology in three physiographic zones in the
Senegal River Basin. Acta Trop 2008, 105:145–153.
22. Sarr JB, Remoue F, Samb B, Dia I, Guindo S, Sow C, Maiga S, Tine S, Thiam C,
Schacht AM, Simondon F, Konate L, Riveau G: Evaluation of antibody
response to Plasmodium falciparum in children according to exposure of
Anopheles gambiae s.l. or Anopheles funestus vectors. Malar J 2007, 6:117.
23. Beier JC, Killeen GF, Githure JI: Short report: entomologic inoculation rates
and Plasmodium falciparum malaria prevalence in Africa. Am J Trop Med
Hyg 1999, 61:109–113.
24. Hay SI, Guerra CA, Tatem AJ, Atkinson PM, Snow RW: Urbanization, malaria
transmission and disease burden in Africa. Nat Rev Microbiol 2005,
3:81–90.
25. Robert V, Le Goff G, Andrianaivolambo L, Randimby FM, Domarle O,
Randrianarivelojosia M, Raharimanga V, Raveloson A, Ravaonjanahary C,
Ariey F: Moderate transmission but high prevalence of malaria in
Madagascar. Int J Parasitol 2006, 36:1273–1281.
26. Guthmann JP, Llanos-Cuentas A, Palacios A, Hall AJ: Environmental factors
as determinants of malaria risk. A descriptive study on the northern
coast of Peru. Trop Med Int Health 2002, 7:518–525.
27. Koita OA, Sangare L, Sango HA, Dao S, Keita N, Maiga M, Mounkoro M,
Fane Z, Maiga AS, Traore K, Diallo A, Krogstad DJ: Effect of seasonality and
Sagna et al. Malaria Journal 2013, 12:301 Page 9 of 9
http://www.malariajournal.com/content/12/1/301ecological factors on the prevalence of the four malaria parasite species
in northern mali. J Trop Med 2012, 2012:367160.
28. Males S, Gaye O, Garcia A: Long-term asymptomatic carriage of
Plasmodium falciparum protects from malaria attacks: a prospective
study among Senegalese children. Clin Infect Dis 2008, 46:516–522.
29. Alves FP, Gil LH, Marrelli MT, Ribolla PE, Camargo EP, Da Silva LH:
Asymptomatic carriers of Plasmodium spp. as infection source for malaria
vector mosquitoes in the Brazilian Amazon. J Med Entomol 2005, 42:777–779.
30. Stone W, Bousema T, Jones S, Gesase S, Hashim R, Gosling R, Carneiro I,
Chandramohan D, Theander T, Ronca R, Modiano D, Arca B, Drakeley C:
IgG responses to Anopheles gambiae salivary antigen gSG6 detect
variation in exposure to malaria vectors and disease risk. PLoS One 2012,
7:e40170.
31. Badu K, Siangla J, Larbi J, Lawson BW, Afrane Y, Ong’echa J, Remoue F,
Zhou G, Githeko AK, Yan G: Variation in exposure to Anopheles gambiae
salivary gland peptide (gSG6-P1) across different malaria transmission
settings in the western Kenya highlands. Malar J 2012, 11:318.
32. Drame PM, Diallo A, Poinsignon A, Boussari O, Dos Santos S, Machault V,
Lalou R, Cornelie S, Lehesran JY, Remoue F: Evaluation of the effectiveness
of malaria vector control measures in urban settings of dakar by a
specific anopheles salivary biomarker. PLoS One 2013, 8:e66354.
33. Drame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC,
Foumane V, Dos-Santos MA, Sembene M, Fortes F, Simondon F, Carnevale
P, Remoue F: Human antibody responses to the Anopheles salivary
gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in
malaria vector control. PLoS One 2010, 5:e15596.
34. Pomelova VG, Osin NS: Prospects of the integration of dry blood spot
technology with human health and environmental population studies.
Vestn Ross Akad Med Nauk 2007:10–16. http://pubget.com/paper/18225500.
35. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ:
Factors determining the occurrence of submicroscopic malaria infections
and their relevance for control. Nat Commun 2012, 3:1237.
36. Okell LC, Ghani AC, Lyons E, Drakeley CJ: Submicroscopic infection in
Plasmodium falciparum-endemic populations: a systematic review and
meta-analysis. J Infect Dis 2009, 200:1509–1517.
37. Berry A, Benoit-Vical F, Fabre R, Cassaing S, Magnaval JF: PCR-based
methods to the diagnosis of imported malaria. Parasite 2008, 15:484–488.
38. de Monbrison F, Angei C, Staal A, Kaiser K, Picot S: Simultaneous
identification of the four human Plasmodium species and quantification
of Plasmodium DNA load in human blood by real-time polymerase
chain reaction. Trans R Soc Trop Med Hyg 2003, 97:387–390.
39. Hanscheid T, Grobusch MP: How useful is PCR in the diagnosis of malaria?
Trends Parasitol 2002, 18:395–398.
doi:10.1186/1475-2875-12-301
Cite this article as: Sagna et al.: Plasmodium falciparum infection during
dry season: IgG responses to Anopheles gambiae salivary gSG6-P1
peptide as sensitive biomarker for malaria risk in Northern Senegal.
Malaria Journal 2013 12:301.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
